Targeted Oral Peptide Icotrokinra for Psoriasis Involving High Impact Sites NEJM Evidence Frontiers Promising strategies in natural products treatments of psoriasis update Many treatment guidelines for psoriasis rely heavily on body surface area (BSA) involvement to determine disease severity and eligibility for systemic therapies like biologics. Traditionally, patients with less than 10% BSA involvementespecially Healthcare Provider Administration of Biologics for Patients with Plaque Psoriasis: Literature Review and Clinical Considerations JCAD The Journal of Clinical and Aesthetic Dermatology Alterations in the cutaneous microbiome of patients with psoriasis and psoriatic arthritis reveal similarities between non lesional and lesional skin Annals of the Rheumatic Diseases